Dr. Rajeev, Executive Vice President and Head of API R&D at Dr. Reddy's, recently shared invaluable insights at CPHI Japan. His session on “Strategic advantages for Japanese companies to partner with Indian manufacturers for sustainable patient access” was both enlightening and empowering. His session was a profound exploration of the synergies between Japanese companies and Indian manufacturers, paving the way for sustainable healthcare solutions and enhanced patient access.
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.